Glaxosmithkline | Dönen Varlıklar



Current Assets Değişiklik Tarih
AbbVie USD 25.58B 2.2B 2024-12
Amgen USD 29.03B 2.26B 2024-12
AstraZeneca USD 25.83B 1.67B 2024-12
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bausch Health Companies USD 5.35B 140M 2024-09
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 471.6M 4.62M 2024-12
Drreddys Laboratories INR 253.02B 4.89B 2024-12
Eli Lilly USD 32.74B 1.32B 2024-12
GlaxoSmithKline GBP 17B 301M 2024-12
Glaxosmithkline GBP 17B 301M 2024-12
Indivior 799M 65M 2024-09
J&J USD 55.89B 2.64B 2024-12
Merck USD 38.78B 1.58B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pacira USD 745.13M 55.16M 2024-12
Perrigo USD 2.48B 1.23B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Prestige Brands USD 377.16M 3.54M 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 30.08B 589M 2024-06
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Takeda JPY 2.75T 299.73B 2024-12
Teva Pharmaceutical Industries USD 12.55B 238M 2024-12
Zoetis USD 5.99B 296M 2024-12



Glaxosmithkline Dönen Varlıklar - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Mar 2025.